Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Healthcare stocks may struggle to find momentum as the Democrats get ready to take over Congress.
Berkshire Hathaway said Saturday it accelerated its share repurchases during the third quarter, as operating and overall profits took a hit.
Groups and strategists advising Democrats are warning them to use their investigative tools on corporate interests, rather than on President Donald Trump.
November 06, 2026
San Francisco Fed President Daly says higher rates ‘are likely to be needed’ in inflation fight
Daly called Friday’s jobs report “good news for American workers,” but noted the pressure inflation is exerting on household finances
Coreweave’s steep yields reflect stress in the AI debt markets as investors worry about a data center slowdown. What comes next.
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Researchers are exploring fetal gene editing to treat rare genetic disorders before they cause lasting damage.
Nasdaq’s slide into correction territory puts its history of recoveries in focus. Here’s what history shows.
November 05, 2026
Top Democrats call to rein in AI buildout after midterms sweep: ‘National data center moratorium now’
Democratic winners and progressive lawmakers are calling for tougher limits on AI and data centers after the 2026 midterm elections.
The Investing Club holds its “Morning Meeting” every weekday at 10:20 a.m. ET.
November 05, 2026
Barkin sees interest rate hikes ahead, but at a gradual pace
In a CNBC interview, the policymaker expressed concern over inflation and said monetary policy will need to adjust.